Company profile
Link Cell Therapies
A True CAR T Cell AND-Gate
- Industry
- Biotechnology Research
- Employees
- 28
- Headquarters
- South San Francisco, CA
- Founded
- 2022
- LinkedIn followers
- 6,189
- Office locations
- 1
Link Cell Therapies company summary
Link Cell Therapies is a company in the Biotechnology Research industry, headquartered in South San Francisco, CA, founded in 2022. On LinkedIn the company has around 28 employees and 6,189 followers.
What technology does Link Cell Therapies use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Link Cell Therapies
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
Where is Link Cell Therapies located?
Link Cell Therapies lists 1 location.
Compare companies similar to Link Cell Therapies
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Link Cell Therapies linkcelltx.com | Biotechnology Research | 28 | 2022 | South San Francisco, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Link Cell Therapies
What does Link Cell Therapies do?
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
How many employees does Link Cell Therapies have?
Link Cell Therapies has around 28 employees on LinkedIn.
Where is Link Cell Therapies headquartered?
Link Cell Therapies is headquartered in South San Francisco, CA.
When was Link Cell Therapies founded?
Link Cell Therapies was founded in 2022.
Build a lead list from companies like Link Cell Therapies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.